Overview

Parrying the Pitfalls of PrEP: Project PEACH

Status:
Not yet recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
The study is a prospective cohort of young Black MSM who are followed for 2 years either in-person at the PRISM Health Research Clinic and/or virtually with telehealth study visits. Follow-up visits occur as frequently as every 3 months, or as appropriate to clinical needs of HIV PrEP or STI PEP. The investigators will enroll men who are not on PrEP at study initiation and who may decide to start or stop PrEP, change from daily oral PrEP to on-demand PrEP or from on-demand PrEP to daily PrEP, and/or start or stop STI PEP at any point in the study period. If there is trouble enrolling men who are not currently on PrEP, the investigators will expand enrollment criteria to include men currently on PrEP. All men will be provided with the study's mobile smart phone app to support early identification of risks for PrEP discontinuation, to provide information about STI PEP and document usage patterns of on-demand PrEP and STI PEP, and to support easy linkage to support services for PrEP counseling and addressing concerns or questions about STI PEP.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Doxycycline
Emtricitabine
Tenofovir